amaducci, l. Phosphatidylserine in the treatment of Alzheimer’s disease: results of a multicenter study. psychofarmaco.bull. 1988;24(1):130-134. see summary.
emmelot, p. and van Hoeven, R. p. phospholipid unsaturation and organization of the plasma membrane. chem phys.lipids 1975;14(3):236-246. see summary.
gatti, c., cantelmi, m. g., brunetti, m., gaiti, a., calderini, g., and teolato, s. Effect of chronic treatment with phosphatidylserine on phospholipase a1 and a2 activities in different brain areas of 4- and 24-month-old rats. pharmaco science 1985;40(7):493-500. see summary.
gindin, j., novikov, m., kedar, d., walter-ginzburg, a., naor, s., and levi, s. The effect of vegetable phosphatidylserine on age-associated memory impairment and mood in the functional elderly. geriatric education and research institute and department of geriatrics; kaplan hospital; Rehovot, Israel 1995;
Jager, R., Purple, M., Geiss, K. R., Weiss, M., Baumeister, J., Amatulli, F., Schroder, L. and Herwegen, H. the effect of phosphatidylserine on golf performance. jint soc.sports nutr 2007;4(1):23. see summary.
child, p. meter. phosphatidylserine; membrane nutrient for memory. a clinical and mechanistic evaluation. alternative medicine rev 1996; 1:70-84.
monteverde, a., gnemmi, p., rossi, f., monteverde, a., and finali, g. c. Selegiline in the treatment of mild to moderate Alzheimer’s dementia. clin.ther 1990;12(4):315-322. see summary.
nerozzi, d., aceti, f., melia, e., magnani, a., Marino, r., genovesi, g., amalfitano, m., cozza, g., murgiano, s., de, Giorgis G., and . [Phosphatidylserine and memory disorders in the elderly]. clin.ter. 3-15-1987;120(5):399-404. see summary.
palmieri, g., palmieri, r., inzoli, mr lombardi g., sottini, c., tavolato, b., and giometto, b. Double-blind controlled trial of phosphatidylserine in patients with senile mental deterioration. clin trials j 1987;24:73-83.
pepper, j. phosphatidylserine. i am j health syst.pharm. 10-15-1999;56(20):2038, 2043-2038, 2044. See abstract.
Ransmayr, G., Plorer, S., Gerstenbrand, F., and Bauer, G. Double-blind placebo-controlled trial of phosphatidylserine in elderly patients with arteriosclerotic encephalopathy. clin trials j 1987;24:62-72.
Read more: What are the most common types of felonies and their penalties?
rosadini, g., sannita, w. g., nobili, f., and cenacchi, t. phosphatidylserine: quantitative eeg effects in healthy volunteers. neuropsychobiology 1990;24(1):42-48. see summary.
starks, m. a., starks, s. L., Kingsley, M., Purple, M., and Jager, R. the effects of phosphatidylserine on the endocrine response to moderate-intensity exercise. jint soc.sports nutr 2008;5:11. see summary.
Vakhapova, V., Cohen, T., Richter, Y., Herzog, Y. and Korczyn, A. d. Phosphatidylserine containing omega-3 fatty acids may improve memory ability in non-demented elderly with memory problems: a double-blind, placebo-controlled trial. dement.geriatr cogn disord 2010;29(5):467-474. see summary.
villardita, j. c., grioli, s., salmeri, g., nicoletti, f., and pennisi, g. Multicenter clinical trial of brain phosphatidylserine in elderly patients with intellectual impairment. clin trials j 1987;24:84-93.
amaducci l. Phosphatidylserine in the treatment of Alzheimer’s disease: results of a multicenter study. psychopharmacology bull 1988;24:130-4.
Benton D, Donohoe Rt, Sillance B, Nabb S. The influence of phosphatidylserine supplementation on mood and heart rate when faced with an acute stressor. nutr neurosci 2001;4:169-78. see summary.
blokland a, honig w, brouns f, jolles j. Cognition-enhancing properties of subchronic phosphatidylserine (PS) treatment in middle-aged rats: comparison of PS from bovine cortex with PS from egg and PS from soybean. nutrition 1999;15:778-83. see summary.
bruton a, nauman j, hanes d, gard m, senders a. Phosphatidylserine for the treatment of pediatric attention deficit/hyperactivity disorder: a systematic review and meta-analysis. j alternative complement med. 2021;27(4):312-322. see summary.
cenacchi t, bertoldin t, farina c, et al. Cognitive impairment in the elderly: a multicenter, double-blind, placebo-controlled study of the efficacy of phosphatidylserine administration. aging (milano) 1993;5:123-33. see summary.
thief t, petrie w, wells c, massari dc. Effects of phosphatidylserine in Alzheimer’s disease. psychopharmacology bull 1992;28:61-6. see summary.
crook th, tinklenberg j, yesavage j, et al. Effects of phosphatidylserine on age-associated memory impairment. neurology 1991;41:644-9. see summary.
Read more: What are the Implications of the Overturning of Roe v. Wade for Racial Disparities? | KFF
Delwaide PJ, Gyselynck-Mambourg AM, Hurlet A, Ylieff M. Double-blind, randomized, controlled study of phosphatidylserine in senile patients with dementia. acta neurol scan 1986;73:136-40. see summary.
engel rr, satzger w, gunther w, et al. double-blind crossover study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type. eur neuropsychopharmacol 1992;2:149-55. see summary.
fahey td, pearl mrs. Hormonal and perceptual effects of phosphatidylserine administration during two weeks of resistance exercise-induced overtraining. biological sport 1998;15:135-44.
fda. qualified health declaration: final decision letter – phosphatidylserine and cognitive dysfunction and dementia. May 2003. Available at: https://wayback.archive-it.org/7993/20171114183737/https://www.fda.gov/food/ingredientspackaginglabeling/labelingnutrition/ucm072999.htm. accessed March 18, 2020.
funfgeld ew, baggen m, nedwidek p, et al. double-blind study with phosphatidylserine (ps) in parkinsonian patients with senile dementia of the alzheimer type (sdat). prog clin biol res 1989;317:1235-46. see summary.
heiss wd, kessler j, mielke r, et al. Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer’s disease. neuropsychological, electroencephalographic and pet research. dementia 1994;5:88-98. see summary.
hirayama s, terasawa k, rabeler r, et al. The effect of phosphatidylserine administration on memory and symptoms of attention deficit hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial. diet j hum nutr. 2014;27 Supplement 2:284-91. see summary.
child pm. attention deficit/hyperactivity disorder (adhd) in children: justification for its integrative management. alternative medicine rev 2000;5:402-28. see summary.
child pm. phosphatidylserine; membrane nutrient for memory. a clinical and mechanistic evaluation. alternative medicine rev 1996; 1:70-84.
kim hy, akbar m, lau a, et al. inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). role of phosphatidylserine in the antiapoptotic effect. j biol chem 2000;275:35215-23.. see abstract.
maggioni m, picotti gb, bondiolotti gp, et al. Effects of phosphatidylserine therapy in geriatric patients with depressive disorders. acta psychiatr scand 1990;81:265-70. see summary.
Read more: Potatoes au Gratin (Dauphinoise) | RecipeTin Eats
mallat z, benamer h, hugl b, et al. Elevated levels of detached membrane microparticles with procoagulant potential in peripheral circulating blood of patients with acute coronary syndromes. circulation 2000;101:841-3.. see abstract.
monastra g, cross ah, bruni a, et al. phosphatidylserine, a putative tumor necrosis factor inhibitor, prevents autoimmune demyelination. neurology 1993;43:153-63.. see abstract.
monteleone p, beinat l, tanzillo c, et al. Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans. neuroendocrinology 1990;52:243-8.. see abstract.
monteleone p, maj m, beinat l, et al. Chronic phosphatidylserine administration blunting of stress-induced activation of the hypothalamic-pituitary-adrenal axis in healthy men. eur j clin pharmacol 1992;42:385-8.. see abstract.
palmieri g, palmieri r, inzoli mr, et al. Double-blind controlled trial of phosphatidylserine in patients with senile mental deterioration. clin trials j 1987;24:73-83.
pepper j. phosphatidylserine. am j health-syst pharm 1999;56:2038,2043-4.
schreiber s, kampf-sherf o, gorfine m, et al. An open-label trial of plant-derived phosphatidylserine for the treatment of age-related cognitive decline. isr j psychiatry relat sci 2000;37:302-7. see summary.
vakhapova v, cohen t, richter y, herzog y, kam y, korczyn ad. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in older people without dementia with memory problems: results of an open-label extension study. dementia geriatric cognitive disorder. 2014;38(1-2):39-45. see summary.
villardita c, grioli s, salmeri g, et al. Multicenter clinical trial of brain phosphatidylserine in elderly patients with intellectual impairment. clin trials j 1987;24:84-93.
wells aj, hoffman jr, gonzalez am, et al. phosphatidylserine and caffeine attenuate post-exercise mood disorders and perception of fatigue in humans. nutres 2013;33:464-72. see summary.
yamazaki m, inoue a, koh cs, et al. Phosphatidylserine suppresses theiler’s murine encephalomyelitis virus-induced demyelinating disease. j neuroimmunol 1997;75:113-22.. see abstract.
zanotti a, valzelli l, toffano g. Chronic phosphatidylserine treatment improves spatial memory and passive avoidance in aged rats. psychopharmacology (berl) 1989;99:316-21.. see abstract.
